TAVR procedure | sciencenewsnet.in

Randomized Trial Studies Device Designed to Reduce Embolic Events in Patients Undergoing TAVR

October 15, 2020 sarah Jonas Heart Disease, Interventional Cardiology, structural heart disease, TAVR heart team, TAVR procedure

The REFLECT II randomized clinical trial evaluating the safety and efficacy of a device designed to reduce cerebral embolization and ischemic stroke, complications of transcatheter aortic valve replacement (TAVR), found that the device met the primary safety endpoint compared to historical controls but did not demonstrate superiority of the device for the primary hierarchical efficacy endpoint.

Research Results

New Bioprosthetic Valve for TAVR Fails to Demonstrate Non-Inferiority

October 15, 2020 sarah Jonas Aortic Stenosis, Heart Disease, structural heart disease, TAVR, TAVR heart team, TAVR procedure, transcatheter aortic valve replacement

In a randomized clinical trial, SCOPE II, a new self-expanding bioprosthetic valve used in transcatheter aortic valve replacement (TAVR) failed to demonstrate non-inferiority compared to an existing self-expanding valve.

Announcement

TCT Connect Agenda Now Available

October 5, 2020 sarah Jonas Angioplasty, Cardiology, Cardiology and Covid-19, Coronary Artery Disease, Endovascular, Interventional Cardiology, PCI, Stents, structural heart disease, TAVR, TAVR heart team, TAVR procedure

The TCT Connect agenda is now available online. TCT, the annual scientific symposium of CRF and the world’s premier educational meeting specializing in interventional cardiovascular medicine, will take place online October 14-18. Every year, TCT features major medical research breakthroughs and gathers leading researchers and clinicians from around the globe to present and discuss the latest evidence-based research in the field.

Announcement

Announcing the TCT Connect Late-Breaking Trials and Science

September 17, 2020 sarah Jonas Angioplasty, Cardiology, Coronary Artery Disease, Heart Disease, Interventional Cardiology, PCI, Percutaneous Coronary Intervention, structural heart disease, TAVR, TAVR procedure

The Cardiovascular Research Foundation (CRF) has announced over 30 late-breaking trial and science presentations that will be reported at TCT Connect. TCT, the annual scientific symposium of CRF and the world’s premier educational meeting specializing in interventional cardiovascular medicine, will take place online October 14-18.

Announcement

Registration for TCT Connect Now Open

September 3, 2020 sarah Jonas Angioplasty, Cardiology, coronary angiography, Coronary Heart Disease, Endovascular, Interventional Cardiology, Percutaneous Coronary Intervention, structural heart disease, TAVR heart team, TAVR procedure, transcatheter aortic valve replacement

The Cardiovascular Research Foundation (CRF) is pleased to announce that registration for the annual scientific symposium, TCT Connect, taking place online October 14-18, is free for all attendees and is now open.

Announcement

Baylor Scott & White Health Again Recognized as Most Awarded Not-for-profit Health System in Texas by U.S. News & World Report

July 28, 2020 sarah Jonas Abdominal Aortic Aneurysm, Aortic Valve Replacement, Cancer, Cardiovascular, Congestive Heart Failure, COPD, Gastroenterology, Gynecology, Healthcare System, Heart, Hip Replacement, integrated health care delivery systems, Knee Replacement, Lung Cancer, Nephrology, Neuroscience, Neurosciences, Neurosurgery, Not For Profit Hospitals, Orthopedic, Pulmonology, specialty care, TAVR, TAVR procedure, Urology, Us News & World Report, US News & world report best hospital rankings, US News & World Report rankings, US News and World Report, US News rankings

In the midst of the extraordinary health challenge presented by the COVID-19 pandemic, Baylor Scott & White Health remains committed to quality, safe care and helping Texas communities navigate the uncertainty of the SARS-CoV-2 virus. Today, this commitment to safety and quality is recognized as U.S. News & World Report releases its 2020-2021 Best Hospitals list.

Announcement

TCT 2020 Is Now a Virtual Event: TCT Connect

May 28, 2020 sarah Jonas Angioplasty, Cardiology, Coronary Artery Disease, Endovascular, Heart Disease, Interventional Cardiology, Percutaneous Coronary Intervention, structural heart disease, TAVR heart team, TAVR procedure, transcatheter aortic-valve replacement

The Cardiovascular Research Foundation (CRF) has announced that Transcatheter Cardiovascular Therapeutics (TCT) 2020 will now take place as a virtual event called TCT Connect. The event will take place online October 14-18, 2020 and feature live case-based transmissions from around the globe, late-breaking clinical trials and science, virtual training, and countless opportunities to learn and engage with the brightest minds in interventional cardiovascular medicine.

Research Results

New TAVR System Safe and Effective for High-Risk Surgical Patients with Severe Aortic Stenosis

September 30, 2019 sarah Jonas 0 Comments Aortic Stenosis, Cardiology, Interventional Cardiology, TAVR, TAVR procedure

The Portico IDE study found that 30-day safety and one-year effectiveness outcomes of a novel self-expanding transcatheter aortic valve replacement (TAVR) system for patients with severe aortic stenosis (AS) at high or extreme-risk for surgery was noninferior to contemporary FDA-approved TAVR systems available in the United States.

Research Results

New Five-Year Data Shows Similar Outcomes for TAVR and SAVR in Patients with Severe Aortic Stenosis and Intermediate Surgical Risk

September 30, 2019 sarah Jonas 0 Comments Aortic Stenosis, Cardiology, Interventional Cardiology, TAVR, TAVR procedure

Five-year results from the PARTNER 2A trial found that patients with severe aortic stenosis (AS) and intermediate surgical risk who underwent transcatheter aortic valve replacement (TAVR) had similar rates of death and disabling stroke compared to those who had surgical aortic valve replacement (SAVR). However, TAVR using a transthoracic approach had poorer outcomes compared to SAVR.